Axsome Therapeutics, Inc.

Behavioral symptoms of Alzheimer’s disease, such as agitation, are reported in up to 70% of all patients with Alzheimer’s disease. Learn more about resources available for people with Alzheimer’s and their loved ones here: https://bit.ly/3Xda1yh #AlzheimersAwarenessMonth

Looking to make a difference? Check out these open roles where you can join a team on a mission to improve the lives of people with hard-to-treat CNS disorders. Learn about our featured open roles in the video below and see all our open roles here: https://bit.ly/3s2Ykwx #hiring

More than 37 million Americans suffer from migraine disorder making it one of the leading causes of disability amongst neurological disorders in the U.S. Check here to learn more about migraine and available resources: https://bit.ly/3VsJrzG #MigraineAwareness #MHAM2024

Alzheimer’s disease is the most common form of dementia, affecting nearly 7 million people in the United States alone. Learn more about resources available for people with Alzheimer’s and their loved ones here: https://bit.ly/3Xda1yh #AlzheimersAwarenessMonth

We have five presentations, including two featured oral plenary presentations, on solriamfetol at SLEEP 2024. Come and meet us at the conference and check here to learn more about the presentations: https://bit.ly/4e3AoN5 #SLEEP2024

Please join us at the American Society of Clinical Psychopharmacology Annual Meeting for multiple data presentations. Learn more about the presentations here: https://bit.ly/4dVsnJX #ASCP2024

This year for Fibromyalgia Awareness Day we are sharing resources to help support the 5 million people affected by fibromyalgia in the United States and to educate others. Helping raise awareness of the impact that fibromyalgia can have on people’s lives is an important first step in addressing the great unmet need for new treatment options for this debilitating condition. Learn more about fibromyalgia here: https://bit.ly/3UxGDQ0 #FibromyalgiaAwarenessDay #Fibromyalgia

Fewer than half of U.S. adults with mental illness received treatment in 2021. Many free online resources and tools are available to provide support for people with mental illness. Learn more about mental health and the resources available here: https://bit.ly/3WvvAK1 #MentalHealthMonth

Mental health conditions are extremely prevalent in the United States, affecting almost half of the population.   Axsome is developing novel therapies for some of the hardest to treat mental health conditions, to help address the most important patient needs. Learn more about our research and development efforts here: https://bit.ly/3wgwHCx #MentalHealthMonth

Please join us at the 2024 American Academy of Neurology (AAN) Annual Meeting where we have presentations that highlight our innovative neuroscience portfolio. Learn more about our presentations at AAN here: https://bit.ly/3W3cRVN #AANAM #psychiatry #neurology